Low-Value Prostate Cancer Screening Common in Primary Care
Providers who order several tests are more likely to order low-value prostate cancer screening
UGN-101 Reviewed in Real-World Upper Tract Urothelial Cancer Setting
For patients with low-grade residual disease, complete response rate was 70 percent with UGN-101
Patient-Centered Texting Platform Beneficial for Interstitial Cystitis
Text message-based platform enhances self-efficacy for managing symptoms of IC/bladder pain syndrome
Nomogram Predicts Upper Urinary Tract Damage in Pediatric Neurogenic Bladder
Nomogram showed good discrimination, with areas under the curve of 0.806 and 0.831 in training, validation cohorts
PCP-Specialist Cotraining Improves Patient Experiences
Adjusted composite patient rating of specialist care higher in association with cotraining of PCPs and specialists
Women With Employer Insurance More Likely to Report Unaffordability of Care
Highest reported unaffordability seen for dental care, followed by prescription drugs, medical care, mental health care
Ransomware Attacks on Health Care Organizations on the Rise
Nearly twofold increase in annual number of attacks seen from 2016 to 2021, exposing information of nearly 42 million patients
5α-Reductase Inhibitors Linked to Depression, but Not Dementia
Magnitude of association for finasteride and dutasteride with dementia decreased over time and became nonsignificant
1990 to 2019 Saw Improvement in Women’s Representation in Academic Medicine
However, representation of underrepresented minorities only increased modestly overall
Per-Patient Costs of Metastatic Prostate Cancer Estimated at $31,427
Increase in annual attributable costs observed over time, from $28,311 in 2007-2013 to $37,055 in 2014-2017
